Clinical Trial Update: Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab with combination chemotherapy before surgery for locally advanced esophageal or gastroesophageal junction cancer; trial com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastroesophageal Junction Adenocarcinoma
• Stomach Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Combination chemotherapy

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction | Phase 2 | Status: COMPLETED | Results posted: 2022-09-07